Protagenic Therapeutics
$0.69
9
+$0.05+7.08% Wednesday 20:00
Statistics
Day High
0.71
Day Low
0.64
52W High
1.87
52W Low
0.49
Volume
34,585
Avg. Volume
239,404
Mkt Cap
2.71M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19NovExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PTIX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sage Therapeutics
SAGE
Mkt Cap514.65M
Alkermes
ALKS
Mkt Cap4.68B
Acadia Pharmaceuticals
ACAD
Mkt Cap2.75B
BridgeBio Pharma
BBIO
Mkt Cap5.24B
Axsome Therapeutics
AXSM
Mkt Cap4.27B
Insmed
INSM
Mkt Cap13.14B
Neurocrine Biosciences
NBIX
Mkt Cap12.83B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap21.38B
About
Internet Software/Services
Technology Services
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
Show more...
CEO
Employees
1
Country
US
ISIN
US74365N1037